Skip to content
    Font Size
    A
    A
    A

    Prostate Cancer Screening: Benefits Outweigh Risks

    Researchers Say Prostate Cancer Screening Nearly Halves Mortality Rate
    By Katrina Woznicki
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    July 1, 2010 -- Screening men for prostate cancer cut mortality rates by about half in a large study, researchers report.

    The screening test under investigation is called a prostate-specific antigen (PSA) test, which measures blood levels of a protein produced by prostate gland cells and is a marker for prostate cancer. PSA is considered a controversial screening test because it can detect cancers that may not advance during a man’s natural life span, resulting in possible over-treatment and reduced quality of life.

    These latest findings, published in the July 1 issue of Lancet Oncology, could shed new light on the potential benefits of PSA screening. Last year, the American Urological Association recommended that men begin undergoing prostate cancer screening at age 40 instead of age 50, the group’s previous recommendation. This revision was criticized by some prostate cancer experts because of concerns that extensive screening would lead to over-diagnosis of the disease and create unnecessary anxiety among patients.

    PSA Test Cuts Prostate Cancer Deaths

    In this study, Jonas Hugosson of the University of Gothenburg in Sweden and colleagues tried to determine whether the benefits of prostate cancer screening outweighed the risks. They randomly divided 20,000 men born between 1930 and 1944 into two groups; every two years, one group received the prostate-specific antigen test while the second group, known as the control group, did not undergo screening. If the PSA test result reached a predetermined abnormal level, the men underwent follow-up testing, such as digital rectal exams, prostate ultrasounds, and biopsies.

    The researchers found that during 14 years of follow up:

    • Prostate cancer was diagnosed in 11.4% of the screening group vs. 7.2% of the control group.
    • Among men with detected prostate cancer in the screening group, 78.7% were diagnosed as a result of enrolling in the study.
    • Among this 78.7%, a total of 231 men had their cancer detected during the first round of screening and 665 men had their cancers detected during subsequent rounds of screening.
    • Cancers were detected on average earlier in the screening group; advanced prostate cancer was detected in 46 patients in the screening group vs. 87 in the control group.
    1 | 2 | 3

    Today on WebMD

    man with doctor
    Symptoms, risks, treatments
    man coughing
    Men shouldn’t ignore
     
    prostate cancer cells
    What does this diagnosis mean?
    doctor and male patient
    Is it worth it?
     
    cancer fighting foods
    SLIDESHOW
    15 Cancer Symptoms Men Ignore
    FEATURE
     
    Prostate Enlarged
    VIDEO
    Picture Of The Prostate
    ANATOMY
     
    Prostate Cancer Quiz
    QUIZ
    screening tests for men
    SLIDESHOW
     
    Prostate Cancer Symptoms
    VIDEO
    Vitamin D
    SLIDESHOW